View Cart (0 items)

Pharmaceutical

Synutra provides government testing results regarding infant formula safety

No Comments
Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan;
Read More

Watson buys Strides'' Australia unit for $396 mln

No Comments
BANGALORE and MUMBAI — U.S.-based Watson Pharmaceuticals Inc said it bought the Australian and South East Asian generic drugs business of Strides Arcolab for A$375 million, reports Reuters.
Read More

Bristol-Myers Squibb donates $6.9 million to support cancer patients

No Comments
PRINCETON, N.J. — Bristol-Myers Squibb Company today announced a donation of $6.9 million to support the HealthWell Foundation, an independent non-profit organization that provides financial assistance to eligible individuals
Read More

Former research chemist pleads guilty to stealing trade secrets

No Comments
TRENTON, N.J. — A former Sanofi-Aventis research chemist has pleaded guilty to stealing trade secrets, CourierPostOnline.com reported. Yuan Li, a 29-year-old Chinese national, admitted to accessing, downloading and making
Read More

Bristol-Myers Squibb to acquire biopharm company

No Comments
NEW YORK — Bristol-Myers Squibb has agreed to acquire biopharmaceutical company Inhibitex for $26.00 per share, according to a press release. The transaction, with an aggregate purchase price of
Read More

J&J knowingly sold defective insulin pumps, FDA says

No Comments
WASHINGTON — The Food and Drug Administration has accused Johnson & Johnson’s Animas unit of continuing to sell insulin pumps last year after learning of defects with the devices,
Read More

Novartis recalls over-the-counter drugs

No Comments
BASEL, Switzerland — Novartis announced Sunday that it is recalling a number of over-the-counter drugs, including certain bottles of Excedrin and Bufferin, due to complaints about chipped and broken
Read More

Pfizer ordered to pay $45 million in menopause drug case

No Comments
NEW YORK — An appeals court has ordered Pfizer Inc. to pay more than $45 million in damages to two women who claimed they developed breast cancer after taking
Read More

New Teva CEO plans to shift focus to branded drugs

No Comments
ERUSALEM — Teva Pharmaceutical Industries new CEO Jeremy Levin said he plans to shift the company’s focus from generics to branded drugs, The Economic Times reported. Levin, a former
Read More

Merck to pay $24 million to settle Medicaid fraud lawsuit

No Comments
BOSTON — Merck & Co. has agreed to pay $24 million to settle allegations that it overcharged the Massachusetts state Medicaid program, The Boston Globe reported. The settlement represents
Read More